We are currently advertising one fully-funded PhD project and the application deadline is Friday 21 June 2024. Below you will find a link to further information about our application process, our ...

The Institute of Cancer Research, London, congratulates the founders of the Chris Lucas Trust, our family charity partner, ...

Michael Parry was diagnosed with pancreatic cancer at the age of 59. Fortunately, his disease was detected early – and after surgery and chemotherapy, he is now planning for the years ahead with his ...

Professor Clare Isacke’s Group investigates the environments surrounding breast cancer cells, in order to understand the molecular basis of the disease’s progression. Professor Clare Isacke aims to ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer. Group: Myeloma ...

The Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics ...

The Chester Beatty Laboratories are on Fulham Road, roughly a 5 minute walk from South Kensington Underground station. Our Corporate Headquarters on Old Brompton Road are a 5 minute walk from both ...

Professor Jyoti Choudhary's group explores the molecular phenotype of cancer studying protein-protein interactions, signalling, post-translational modifications and protein expression. Professor Jyoti ...

Professor Andrea Sottoriva’s group uses biological, clinical and mathematical expertise, in order to decipher how cancer progresses, metastasises and develops treatment resistance. Professor Andrea ...

Professor Udai Banerji champions multidisciplinary working at the interface between early phase clinical trials, drug discovery and translational research related to drug resistance. He is a key ...